 | • レポートコード：GIR201100047 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、20sプロテアソームの世界市場を調査対象にし、20sプロテアソームの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（マリゾミブ、オプロゾミブ、カーフィルゾミブ、VPEA-002、その他）、用途別分析（大腸がん、リンパ腫、悪性神経膠腫、神経内分泌がん、卵巣がん、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Amgen Inc、Celgene Corp ・メーカー別販売量、売上、市場シェア ・20sプロテアソームの地域別市場分析 ・20sプロテアソームの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・20sプロテアソームのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・20sプロテアソームのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・20sプロテアソームの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・20sプロテアソームの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・20sプロテアソームの種類別市場規模2015-2020：マリゾミブ、オプロゾミブ、カーフィルゾミブ、VPEA-002、その他 ・20sプロテアソームの用途別市場規模2015-2020：大腸がん、リンパ腫、悪性神経膠腫、神経内分泌がん、卵巣がん、その他 ・20sプロテアソームの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global 20s Proteasome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The 20s Proteasome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
20s Proteasome market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, 20s Proteasome market has been segmented into
Marizomib
Oprozomib
Carfilzomib
VPEA-002
Others
By Application, 20s Proteasome has been segmented into:
Colon Cancer
Lymphoma
Malignant Glioma
Neuroendocrine Cancer
Ovarian Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global 20s Proteasome market presented in the report. This section sheds light on the sales growth of different regional and country-level 20s Proteasome markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global 20s Proteasome market.
The report offers in-depth assessment of the growth and other aspects of the 20s Proteasome market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and 20s Proteasome Market Share Analysis
20s Proteasome competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, 20s Proteasome sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the 20s Proteasome sales, revenue and market share for each player covered in this report.
The major players covered in 20s Proteasome are:
Amgen Inc
Celgene Corp
Among other players domestic and global, 20s Proteasome market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 20s Proteasome product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 20s Proteasome, with price, sales, revenue and global market share of 20s Proteasome in 2018 and 2019.
Chapter 3, the 20s Proteasome competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 20s Proteasome breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, 20s Proteasome market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe 20s Proteasome sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 20s Proteasome Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global 20s Proteasome Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Marizomib
1.2.3 Oprozomib
1.2.4 Carfilzomib
1.2.5 VPEA-002
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global 20s Proteasome Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Colon Cancer
1.3.3 Lymphoma
1.3.4 Malignant Glioma
1.3.5 Neuroendocrine Cancer
1.3.6 Ovarian Cancer
1.3.7 Others
1.4 Overview of Global 20s Proteasome Market
1.4.1 Global 20s Proteasome Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Amgen Inc Details
2.1.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen Inc SWOT Analysis
2.1.4 Amgen Inc Product and Services
2.1.5 Amgen Inc 20s Proteasome Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celgene Corp
2.2.1 Celgene Corp Details
2.2.2 Celgene Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celgene Corp SWOT Analysis
2.2.4 Celgene Corp Product and Services
2.2.5 Celgene Corp 20s Proteasome Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global 20s Proteasome Sales and Market Share by Manufacturer (2018-2019)
3.2 Global 20s Proteasome Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 20s Proteasome Manufacturer Market Share in 2019
3.3.2 Top 6 20s Proteasome Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global 20s Proteasome Sales, Revenue and Market Share by Regions
4.1.1 Global 20s Proteasome Sales and Market Share by Regions (2015-2020)
4.1.2 Global 20s Proteasome Revenue and Market Share by Regions (2015-2020)
4.2 North America 20s Proteasome Sales and Growth Rate (2015-2020)
4.3 Europe 20s Proteasome Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific 20s Proteasome Sales and Growth Rate (2015-2020)
4.5 South America 20s Proteasome Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa 20s Proteasome Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America 20s Proteasome Sales, Revenue and Market Share by Country
5.1.1 North America 20s Proteasome Sales and Market Share by Country (2015-2020)
5.1.2 North America 20s Proteasome Revenue and Market Share by Country (2015-2020)
5.2 United States 20s Proteasome Sales and Growth Rate (2015-2020)
5.3 Canada 20s Proteasome Sales and Growth Rate (2015-2020)
5.4 Mexico 20s Proteasome Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe 20s Proteasome Sales, Revenue and Market Share by Country
6.1.1 Europe 20s Proteasome Sales and Market Share by Country (2015-2020)
6.1.2 Europe 20s Proteasome Revenue and Market Share by Country (2015-2020)
6.2 Germany 20s Proteasome Sales and Growth Rate (2015-2020)
6.3 UK 20s Proteasome Sales and Growth Rate (2015-2020)
6.4 France 20s Proteasome Sales and Growth Rate (2015-2020)
6.5 Russia 20s Proteasome Sales and Growth Rate (2015-2020)
6.6 Italy 20s Proteasome Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific 20s Proteasome Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific 20s Proteasome Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific 20s Proteasome Revenue and Market Share by Regions (2015-2020)
7.2 China 20s Proteasome Sales and Growth Rate (2015-2020)
7.3 Japan 20s Proteasome Sales and Growth Rate (2015-2020)
7.4 Korea 20s Proteasome Sales and Growth Rate (2015-2020)
7.5 India 20s Proteasome Sales and Growth Rate (2015-2020)
7.6 Southeast Asia 20s Proteasome Sales and Growth Rate (2015-2020)
7.7 Australia 20s Proteasome Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America 20s Proteasome Sales, Revenue and Market Share by Country
8.1.1 South America 20s Proteasome Sales and Market Share by Country (2015-2020)
8.1.2 South America 20s Proteasome Revenue and Market Share by Country (2015-2020)
8.2 Brazil 20s Proteasome Sales and Growth Rate (2015-2020)
8.3 Argentina 20s Proteasome Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa 20s Proteasome Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa 20s Proteasome Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa 20s Proteasome Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia 20s Proteasome Sales and Growth Rate (2015-2020)
9.3 Turkey 20s Proteasome Sales and Growth Rate (2015-2020)
9.4 Egypt 20s Proteasome Sales and Growth Rate (2015-2020)
9.5 South Africa 20s Proteasome Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global 20s Proteasome Sales and Market Share by Type (2015-2020)
10.2 Global 20s Proteasome Revenue and Market Share by Type (2015-2020)
10.3 Global 20s Proteasome Price by Type (2015-2020)
11 Global 20s Proteasome Market Segment by Application
11.1 Global 20s Proteasome Sales Market Share by Application (2015-2020)
11.2 Global 20s Proteasome Revenue Market Share by Application (2015-2020)
11.3 Global 20s Proteasome Price by Application (2015-2020)
12 Market Forecast
12.1 Global 20s Proteasome Sales, Revenue and Growth Rate (2021-2025)
12.2 20s Proteasome Market Forecast by Regions (2021-2025)
12.2.1 North America 20s Proteasome Market Forecast (2021-2025)
12.2.2 Europe 20s Proteasome Market Forecast (2021-2025)
12.2.3 Asia-Pacific 20s Proteasome Market Forecast (2021-2025)
12.2.4 South America 20s Proteasome Market Forecast (2021-2025)
12.2.5 Middle East & Africa 20s Proteasome Market Forecast (2021-2025)
12.3 20s Proteasome Market Forecast by Type (2021-2025)
12.3.1 Global 20s Proteasome Sales Forecast by Type (2021-2025)
12.3.2 Global 20s Proteasome Market Share Forecast by Type (2021-2025)
12.4 20s Proteasome Market Forecast by Application (2021-2025)
12.4.1 Global 20s Proteasome Sales Forecast by Application (2021-2025)
12.4.2 Global 20s Proteasome Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global 20s Proteasome Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of 20s Proteasome by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global 20s Proteasome Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Inc 20s Proteasome Major Business
Table 9. Amgen Inc 20s Proteasome Total Revenue (USD Million) (2018-2019)
Table 10. Amgen Inc SWOT Analysis
Table 11. Amgen Inc 20s Proteasome Product and Services
Table 12. Amgen Inc 20s Proteasome Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Celgene Corp Basic Information, Manufacturing Base and Competitors
Table 14. Celgene Corp 20s Proteasome Major Business
Table 15. Celgene Corp 20s Proteasome Total Revenue (USD Million) (2018-2019)
Table 16. Celgene Corp SWOT Analysis
Table 17. Celgene Corp 20s Proteasome Product and Services
Table 18. Celgene Corp 20s Proteasome Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global 20s Proteasome Sales by Manufacturer (2018-2019) (K Pcs)
Table 20. Global 20s Proteasome Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global 20s Proteasome Sales by Regions (2015-2020) (K Pcs)
Table 22. Global 20s Proteasome Sales Market Share by Regions (2015-2020)
Table 23. Global 20s Proteasome Revenue by Regions (2015-2020) (USD Million)
Table 24. North America 20s Proteasome Sales by Countries (2015-2020) (K Pcs)
Table 25. North America 20s Proteasome Sales Market Share by Countries (2015-2020)
Table 26. North America 20s Proteasome Revenue by Countries (2015-2020) (USD Million)
Table 27. North America 20s Proteasome Revenue Market Share by Countries (2015-2020)
Table 28. Europe 20s Proteasome Sales by Countries (2015-2020) (K Pcs)
Table 29. Europe 20s Proteasome Sales Market Share by Countries (2015-2020)
Table 30. Europe 20s Proteasome Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific 20s Proteasome Sales by Regions (2015-2020) (K Pcs)
Table 32. Asia-Pacific 20s Proteasome Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific 20s Proteasome Revenue by Regions (2015-2020) (USD Million)
Table 34. South America 20s Proteasome Sales by Countries (2015-2020) (K Pcs)
Table 35. South America 20s Proteasome Sales Market Share by Countries (2015-2020)
Table 36. South America 20s Proteasome Revenue by Countries (2015-2020) (USD Million)
Table 37. South America 20s Proteasome Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa 20s Proteasome Sales by Countries (2015-2020) (K Pcs)
Table 39. Middle East & Africa 20s Proteasome Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa 20s Proteasome Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa 20s Proteasome Revenue Market Share by Countries (2015-2020)
Table 42. Global 20s Proteasome Sales by Type (2015-2020) (K Pcs)
Table 43. Global 20s Proteasome Sales Share by Type (2015-2020)
Table 44. Global 20s Proteasome Revenue by Type (2015-2020) (USD Million)
Table 45. Global 20s Proteasome Revenue Share by Type (2015-2020)
Table 46. Global 20s Proteasome Sales by Application (2015-2020) (K Pcs)
Table 47. Global 20s Proteasome Sales Share by Application (2015-2020)
Table 48. Global 20s Proteasome Sales Forecast by Regions (2021-2025) (K Pcs)
Table 49. Global 20s Proteasome Market Share Forecast by Regions (2021-2025)
Table 50. Global 20s Proteasome Sales Forecast by Type (2021-2025) (K Pcs)
Table 51. Global 20s Proteasome Market Share Forecast by Type (2021-2025)
Table 52. Global 20s Proteasome Sales Forecast by Application (2021-2025)
Table 53. Global 20s Proteasome Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. 20s Proteasome Picture
Figure 2. Global Sales Market Share of 20s Proteasome by Type in 2019
Figure 3. Marizomib Picture
Figure 4. Oprozomib Picture
Figure 5. Carfilzomib Picture
Figure 6. VPEA-002 Picture
Figure 7. Others Picture
Figure 8. 20s Proteasome Sales Market Share by Application in 2018
Figure 9. Colon Cancer Picture
Figure 10. Lymphoma Picture
Figure 11. Malignant Glioma Picture
Figure 12. Neuroendocrine Cancer Picture
Figure 13. Ovarian Cancer Picture
Figure 14. Others Picture
Figure 15. Global 20s Proteasome Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia 20s Proteasome Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey 20s Proteasome Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global 20s Proteasome Sales Market Share by Manufacturer in 2019
Figure 36. Global 20s Proteasome Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 20s Proteasome Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 20s Proteasome Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 41. Global 20s Proteasome Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global 20s Proteasome Revenue Market Share by Regions (2015-2020)
Figure 43. Global 20s Proteasome Revenue Market Share by Regions in 2018
Figure 44. North America 20s Proteasome Sales and Growth Rate (2015-2020)
Figure 45. Europe 20s Proteasome Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific 20s Proteasome Sales and Growth Rate (2015-2020)
Figure 47. South America 20s Proteasome Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa 20s Proteasome Sales and Growth Rate (2015-2020)
Figure 49. North America 20s Proteasome Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America 20s Proteasome Sales Market Share by Countries (2015-2020)
Figure 51. North America 20s Proteasome Sales Market Share by Countries in 2018
Figure 52. North America 20s Proteasome Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America 20s Proteasome Revenue Market Share by Countries in 2018
Figure 54. United States 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Canada 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Mexico 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Europe 20s Proteasome Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe 20s Proteasome Revenue Market Share by Countries (2015-2020)
Figure 59. Europe 20s Proteasome Revenue Market Share by Countries in 2019
Figure 60. Germany 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. UK 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. France 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Italy 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Asia-Pacific 20s Proteasome Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific 20s Proteasome Sales Market Share by Regions 2019
Figure 67. Asia-Pacific 20s Proteasome Revenue Market Share by Regions 2019
Figure 68. China 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Korea 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. India 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Southeast Asia 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. South America 20s Proteasome Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America 20s Proteasome Sales Market Share by Countries in 2019
Figure 75. South America 20s Proteasome Revenue Market Share by Countries in 2019
Figure 76. Brazil 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Argentina 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Middle East and Africa 20s Proteasome Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa 20s Proteasome Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa 20s Proteasome Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa 20s Proteasome Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Egypt 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Turkey 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. South Africa 20s Proteasome Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. Global 20s Proteasome Sales and Growth Rate (2021-2025) (K Pcs)
Figure 87. Global 20s Proteasome Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales 20s Proteasome Market Forecast (2021-2025) (K Pcs)
Figure 89. Europe Sales 20s Proteasome Market Forecast (2021-2025) (K Pcs)
Figure 90. Asia-Pacific Sales 20s Proteasome Market Forecast (2021-2025) (K Pcs)
Figure 91. South America Sales 20s Proteasome Market Forecast (2021-2025) (K Pcs)
Figure 92. Middle East & Africa Sales 20s Proteasome Market Forecast (2021-2025) (K Pcs)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
転移性卵巣がん治療薬の世界市場 2020年 Market Overview The global Metastatic Ovarian Cancer Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic Ova…- 尿管がん治療薬の世界市場 2020年 Market Overview The global Ureter Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ureter Cancer Drugs marke…
- 新興がん用ワクチンの世界市場 2020年 Market Overview The global Emerging Cancer Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Emerging Cancer Vacc…
- 乳がん治療薬の世界市場 2020年 Market Overview The global Breast Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast Cancer T…
- がんmTOR阻害剤の世界市場 2020年 Market Overview The global Cancer mTOR Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer mTOR Inhibitors…